Interventional Cardiology Devices Market

Global Interventional Cardiology Devices Market By Type (Angioplasty Stents [Drug-Eluting Stents, Bare-Matal Stents, Bio absorbable Stents], Structural Heart Devices [ Aortic Valve Therapy Devices, and Other Therapy Devices], Catheters [Angiography Catheters, Guiding Catheters, IVU/OCT Catheters], Angioplasty Balloons [Old/Normal Balloons, Drug-Eluting Balloons, Cutting/Scoring Balloons], Plaque Modification Devices [Thrombectomy Devices, Atherectomy Devices ], Hemodynamic Flow Alteration Devices [Embolic Protection Devices, Chronic Total Occlusion Devices ], and Others); By Region (North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: August 2021
  • Report ID: BWC2124
  • Available Format: PDF
  • Page: 200

Report Overview

The field of interventional cardiology deals with treating structural heart diseases using catheters.There are many procedures done on the heart using catheters, including insertion of a catheter into the femoral artery, cannulating the heart under x-ray vision, balloon valvuloplasty, coronary thrombectomy, and cardiac ablation.

The global interventional cardiology devices market was worth USD 13.9 billion in 2020 and is further projected to reach USD 25.3 billion by 2027 at a CAGR of 9.3% during the forecast period (2021-2027). The market for interventional cardiology devices is growing due to an increase in the incidence of cardiovascular disorders such as coronary heart disease, cerebrovascular disease, peripheral artery disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism.According to the World Health Organization, cardiovascular disease is the leading cause of mortality worldwide. Globally, 17.9 million people died from cardiovascular disorders in 2016, with heart attacks and stroke accounting for 85% of death.Technology advancements in guidewires and stent construction have caused the market for interventional cardiology equipment to grow.Diabetes also promotes the market's growth as excess sugar damages coronary blood vessels due to diabetes, which is a significant risk factor for developing heart disease.

interventional cardiology devices market

Source: BlueWeave Consulting

Global Interventional Cardiology Devices Market Overview

The field of interventional cardiology deals with treating structural heart diseases using catheters.There are many procedures done on the heart using catheters, including insertion of a catheter into the femoral artery, cannulating the heart under x-ray vision, balloon valvuloplasty, coronary thrombectomy, and cardiac ablation.With the help of cardiac catheterization, a cardiologist can assess the severity and extent of cardiac problems by analyzing the location and size of the plaque deposition. A cardiologist can determine the heart muscle and valve, collect blood samples, and measure the heart chambers' blood pressure and blood flow using interventional methods.

In coronary angioplasty, also known as percutaneous coronary intervention, arteries that become narrowed due to plaque deposition are widened using stents. Stents are small metal cylinders that are inserted via catheterization into blood vessels and make up a significant segment of the interventional cardiology devices market.The balloon on the tip of the catheter inflates to push plaque against artery walls, which allows blood to flow more freely.The main advantage of interventional cardiology is that there is no postoperative pain, scarring, or recovery time, which accounts for the boom in the market for interventional cardiology devices.Myocardial infarction is treated most effectively with this procedure. The procedure involves removing clots from occluded coronary arteries and inserting stents through a small hole in them, which is why it is referred to as "pinhole surgery".


Global Interventional Cardiology Devices Market Trend

Growth Drivers

Rising prevalence of coronary artery diseases


The increasing prevalence of coronary artery diseases drives the growth of the interventional cardiology devices market. Interventional cardiology devices are used in the catheter-based treatment of structural heart disease. The Center for Disease Control and Prevention (CDC) estimates that approximately 365,914 Americans died from heart disease in 2017. Diabetes and hypertension are also driving the market growth for interventional cardiology devices because these two chronic diseases can cause damage to blood vessels. According to American Diabetes Association, approximately 1.5 million Americans are diagnosed with diabetes each year in the U.S. Additionally, the increasing geriatric population that is more prone to cardiac ailments also drives the growth of the interventional cardiology devices market.

 

Increasing Advancements in the Technology

Rising technological advancements have been driving the growth of the interventional cardiology devices market. Technological advancements in the guidewires and stents segments, such as improved flexibility with low deformity, and excellent tip shape retention are increasing the demand for interventional cardiology devices. For instance, Runthrough NS by Terumo, which can do multi-vessel procedures with one wire, is expected to improve the usage rates. Key companies in the interventional cardiology devices market are investing heavily in the research and development of cardiology devices, such as Medtronic, Boston Scientific, and Abbott, which in turn is driving the growth of interventional cardiology devices market.

 

Restraints

High cost of treatment

The exorbitant cost of interventional cardiology devices is restraining the growth of the interventional cardiology devices market. The National Center for Biotechnology Information reports that the average heart catheterization price in the United States was USD 2,400 in 2020. Thus, the high price of the treatment deters middle-class customers from adopting it as it is only affordable by the wealthy section of society. Moreover, the cost of surgery depends on various other factors like the level of correction, the reputation of the surgeon, and the technology used. Cardiology devices are very expensive, and this complicates the treatment of coronary artery diseases. Thus, the high cost of therapy impedes the growth of the interventional cardiology devices market.

 

Impact of COVID-19 on the Global Interventional Cardiology Devices Market

As a result of COVID-19 spreading in many parts of the world, the world economy had to suffer a massive downturn. The lockdown has created a shortage of laborers in factories. Moreover, the supply chain for raw materials has been disrupted due to travel bans, which in turn have negatively impacted the interventional cardiology devices market.Moreover, travel restrictions have been preventing patients from visiting the hospitals, which lowers the demand for interventional cardiology devices.Also, a lot of hospitals postponed operations, resulting in a decrease in the demand for interventional cardiology devices. This is how COVID-19 has negatively impacted the interventional cardiology devices market.

 

Global Interventional Cardiology Devices Market: By Type

Based on the types of interventional cardiology devices, the market has been divided into seven broad categories: angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, and others. Angioplasty stents are further divided into drug-eluting stents, bare-metal stents, and bioabsorbable stents. Structural heart devices, on the other hand, are divided into aortic valve therapy devices and other therapy devices. Catheters are grouped into angiography catheters, guiding catheters, IVU/OCT catheters. Angioplasty balloons are divided into old/regular balloons, drug-eluting balloons, and cutting/scoring balloons.Also, plaque modification devices are divided into thrombectomy devices and atherectomy devices. Hemodynamic flow alteration devices are further divided into embolic protection devices and chronic total occlusion devices.

Among these, the angioplasty stents segmentdominates the interventional cardiology devices market due to high usage rates in procedures and growing adoption rates of technological advancements such as bio-absorbable stents. Stents are mainly used in minimally invasive percutaneous coronary interventions (PCI) or coronary angioplasty surgeries. The rising prevalence of coronary artery diseases boosts the growth of the stents segment.

interventional cardiology devices market size

Source: BlueWeave Consulting

Global Interventional Cardiology Devices Market: Regional Insights 

Based on the regions, the interventional cardiology devices market is segmented into North America, the Asia-Pacific, Europe, Latin America, and the Middle East & Africa. North America held the largest share in the interventional cardiology devices market in 2020 due to the increasing research and development activities and efficient reimbursement policies. The presence of multiple emerging markets and advanced healthcare systems are also driving the growth of the market. Further, the increasing prevalence of diabetes, which can cause heart diseases, is driving the market for interventional cardiology devices.The American Diabetes Association reports that 1.5 million diabetes cases are reported yearly in the United States.What’s more, the increasing efforts by the US government to create an efficient healthcare system also contributeto the market's growth.

Regional Insights

Source: BlueWeave Consulting

Competitive landscape

The major players in the global interventional cardiology devices market areMedtronic, Boston Scientific Corporation, Abbott, Edward Lifesciences Corporation, Cardinal Health, iVascular , B. Braun Melsungen , Terumo Corporation, Biosensors International Group, and BIOTRONIK SE & Co. KG, Johnson & Johnson, Becton Dickinson, Teleflex Incorporated, MicroPort Scientific Corporation, Cook Medical Inc., GE Healthcare, W. L. Gore & Associates, Inc, REX MEDICAL, W. L. Gore & Associates,OrbusNeich Medical, and other prominent players. By investing in research and development, the companies are aiming to gain market share. Market players compete based on the safety and efficacy of their products, compliance with standards and performance, and efficient manufacturing processes, which increase their revenues.

Recent Developments

  • In June 2021, Q3 Medical Devices Limited received CE mark approval for a dedicated biodegradable metal alloy-based stent, the UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent (BEBS).

 

In June 2021, Sensome, a company that develops ground-breaking remote monitoring technology, received a breakthrough device designation from the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the Clotid Smart Guidewire System.

Attribute

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia, Mexico

Product/Service Segmentation

By Type, and Region.

Key Players

Key Players for the market are Abbott, Edward Lifesciences Corporation, Cardinal Health, iVascular , B. Braun Melsungen , Terumo Corporation, Biosensors International Group, and BIOTRONIK SE & Co. KG, Johnson & Johnson, Becton Dickinson, Teleflex Incorporated, MicroPortScientific Corporation, Cook Medical Inc., GE Healthcare, W. L. Gore & Associates, Inc, REX MEDICAL, W. L. Gore & Associates, ORBUSNEICH MEDICAL, & other prominent players.

 

 

By Type

  • Angioplasty Stents
    • Drug-Eluting Stents
    • Bare-Matal Stents
    • Bioabsorbable Stents

Ø Structural Heart Devices

    • Aortic Valve Therapy Devices
    • Other Therapy Devices

Ø Catheters

    • Angiography Catheters,
    • Guiding Catheter
    • IVU/OCT Catheters

Ø Angioplasty Balloons

    • Old/Normal Balloons
    • Drug-Eluting Balloons
    • Cutting/Scoring Balloons

Ø Plaque Modification Devices

    • Thrombectomy Devices
    • Atherectomy Devices

Ø Hemodynamic Flow Alteration Devices

    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  •  Others

By Region

  • North America
  • Europe
  • The Asia-Pacific
  • Latin America
  • The Middle East & Africa

FAQs:

  1. What is the current size of the global interventional cardiology devices market?

Answer: The global interventional cardiology devices market reached USD 13.9 billion in 2020.

 

  1. What are the major factors driving the growth of the global interventional cardiology devices market?

Answer: Increasing coronary artery diseases and growing technological advancements are the major factors that drive the growth of the market.

  1. Who are the key players in the global interventional cardiology devices market?

Answer: The key players in the global interventional  cardiology devices market are Abbott, Edward Lifesciences Corporation, Cardinal Health, iVascular , B. Braun Melsungen , Terumo Corporation, Biosensors International Group, and BIOTRONIK SE & Co. KG, Johnson & Johnson, Becton Dickinson, Teleflex Incorporated, MicroPort Scientific Corporation, Cook Medical Inc., GE Healthcare, W. L. Gore & Associates, Inc, REX MEDICAL, W. L. Gore & Associates, ORBUSNEICH MEDICAL, and other prominent players.

 

  1. Based on types, which segment accounted for the largest share in the global interventional cardiology devices market?

Answer: Angioplasty stents segment held the largest share in the global interventional cardiology devices market.

  1. Which region has the largest share in global interventional cardiology devices market?

Answer: North America has the largest share in the global interventional cardiology devices market.